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Neurobiology of Disease
The Parkinsonian Mimetic, MPP, Specifically Impairs
Mitochondrial Transport in Dopamine Axons
Jeong Sook Kim-Han,* Jo Ann Antenor-Dorsey,* and Karen L. O’Malley
Department of Anatomy and Neurobiology, Washington University School of Medicine, Saint Louis, Missouri 63110
Impaired axonal transport may play a key role in Parkinson’s disease. To test this notion, a microchamber system was adapted to
segregate axons from cell bodies using green fluorescent protein-labeled mouse dopamine (DA) neurons. Transport was examined in
axons challenged with the DA neurotoxin, 1-methyl-4-phenylpyridinium ion (MPP). MPP rapidly reduced overall mitochondrial
motility in DA axons; amongmotile mitochondria, anterograde transport was slower yet retrograde transport was increased. Transport
effects were specific for DAmitochondria, which were smaller and transportedmore slowly than their non-DA counterparts. MPP did
not affect synaptophysin-tagged vesicles or any other measureable moving particle. Toxin effects on DAmitochondria were not depen-
dent upon ATP, calcium, free radical species, JNK, or caspase3/PKC pathways but were completely blocked by the thiol-anti-oxidant
N-acetyl-cysteine or membrane-permeable glutathione. Since these drugs also rescued processes from degeneration, these findings
emphasize the need to develop therapeutics aimed at axons as well as cell bodies to preserve “normal” circuitry and function as long as
possible.
Introduction
Impaired axonal transport plays an important role in a variety of
neurodegenerative disorders, including Parkinson disease (PD)
(De Vos et al., 2008). Postmortem studies on PD patients show
widespread axonal pathology that appears to precede the loss of
cell bodies (Orimo et al., 2008), supporting the notion that nigral
neurons degenerate through a “dying back” axonopathy (Raff et
al., 2002). Animalmodels of PD-linked genes also point to axonal
impairment as being a critical factor. For example, transgenic
mice expressing the PD-linked R1441G LRRK2mutation exhibit
decreased dopamine (DA) terminal fields togetherwith increased
dystrophic processes and abnormal axonal swellings, findings
consistent with DA axonopathy (Li et al., 2009). Reduced axonal
transport is also seen with -synuclein mutants, which accumu-
late in the cell soma when overexpressed in cortical neurons
(Saha et al., 2004). Moreover, vesicle-associated -synuclein
binds to microtubule motor proteins like kinesin and dynein,
underscoring a potential role in microtubule-dependent axonal
transport (Yang et al., 2010). In addition, genetic mutations in
Parkin, an E3 ligase, and PINK1, a mitochondrially targeted ki-
nase, lead to impaired mitochondrial dynamics, resulting in al-
tered transport and distribution ofmitochondria as well as loss of
synaptic function (Bueler, 2009). PINK1 can also form a complex
withMiro andMilton (Weihofen et al., 2009), proteins known to
recruit kinesin to the mitochondria and promote motility along
microtubule tracks (Reis et al., 2009). Thus, these PD-linkedmu-
tations are consistent with the idea that axonal dysfunction plays
an early and significant role in the disorder.
Environmental toxins mimicking PD such as N-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) or its active deriva-
tive, 1-methyl-4-phenylpyridinium ion (MPP), also disrupt
axonal function. MPTP-treated monkeys (Meissner et al., 2003)
or mice (Serra et al., 2002) first lose DA terminal fields and then
exhibit cell body loss. Moreover, Wallerian degeneration slow
(WldS) mutant mice rescue DA projections in MPTP-treated ani-
mals but not cell bodies, emphasizing the independence of cell body
function versus axon specialization (Hasbani and O’Malley, 2006).
In addition, MPP can directly inhibit axon transport in the squid
axoplasm(Morfini et al., 2007).Althoughthemechanismsunderlying
the latter responseareunclear, invertebratemodelsMPPdepolymer-
izesmicrotubules, leading to axon fragmentation anddecreased synap-
tic function (Cappelletti et al., 2005;Cartelli et al., 2010).
Difficulty in assessing real-time changes in DA axons has pre-
cluded testing models of structural or trafficking impairment.
Although much can be learned from the squid giant axon, this
system as well as studies in vertebrate peripheral, cortical, or
other non-DA cell types (Cartelli et al., 2010), may be unrepre-
sentative of a bona fide DA neuron. Recently, we have adapted a
microchamber system in which axons are segregated to one side,
leaving cell bodies and dendrites on the other. When used with
GFP-labeled DA neurons derived from genetically engineered
mice, DA axons can be examined using targeted fluorescent
markers and time lapse imaging. Using these chambers, here we
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show thatMPP specifically decreasesmitochondrialmovement
in DA axons. We also explore potential mechanisms underlying
the effect of MPP on mitochondrial transport in DA axons.
Materials andMethods
Cell culture and microchamber devices. Murine mesencephalic cultures
were prepared, treated with toxin for indicated time periods, then fixed
and stained for tyrosine hydroxylase (TH) as described previously (Lo-
tharius et al., 1999). TH-positive cell bodies and neurites were counted
using Stereo Investigator (MBF Bioscience). DA/GFP cultures were pre-
pared from embryonic day 14 Tg(TH-EGFP)DJ76GSAT transgenicmice
(Gene Expression Nervous System Atlas, National Institutes of Health,
Bethesda, MD). Typically DA/GFP males were mated with wild-type
females. Brains isolated from the resulting embryos were screened for
GFP fluorescence before midbrain dissection. GFP-positive tissue was
pooled and plated.Microchamber devices weremodified from Ivins et al.
(1998). Briefly, 20mmglass bottom culture dishes (MatTek) were coated
with 100g/mlMatrigel (BD Bioscience), rinsed with DMEM/F-12, and
dried. A polytetrafluoroethylene Teflon tubing [17 (outside diameter)
13 (inside diameter)  2 (wall thickness)  5 mm (length)] was cut in
half and attached to the bottom of the dish using sterile vacuum grease. A
rectangular glass coverslip (9  18 mm) was sandwiched between both
pieces of Teflon and sealed in place with a Matrigel/collagen complex (1
mg/ml collagen type I, 3 mg/ml Matrigel, DMEM). Isolated neurons
(250,000 cells/cm2) were plated on one side of the chamber in DMEM/
F-12, 5% FBS, supplemented with B-27 (Invitrogen) and penicillin/
streptomycin. Axonal chambers were supplemented with 300 g/ml
NetrinI (R&D Systems) to direct axonal outgrowth under the coverslip.
Transport was assessed between days in vitro (DIV) 12 and 14.
Determination of cell viability. To determineDA cell viability following
MPP treatment both in cell bodies and neurites, mesencephalic cul-
tures were processed for TH immunoreactivity and counted using Stereo
Investigator (MBF Bioscience). Briefly, 50 fields were assayed per dish
leading to the quantification of 200–300 TH neurons and 2000–5000
neurites/dish. Experiments were repeated 3–5 times using cultures iso-
lated from independent dissections.
Quantification of tubulin. The tubulin-mCherry construct was pre-
pared by replacing the EGFP sequence of pEGFP-tubulin (Invitrogen)
with mCherry (Dr. Mike Nonet, Washington University, St Louis, MO).
Neurons were transfected using Lipofectamine 2000 (Invitrogen) at
DIV5-6 and imaged 1 d later. Live images were taken at 1, 3, 6, and 24 h
after MPP treatment. Tubulin integrity was also measured by immu-
nostaining with antibodies against tyrosine hydroxylase (Pel-Freez Bio-
logicals) and acetylated tubulin (AcTub; Sigma) on the axonal side of
microchamber devices. TH-positive axons with at least three AcTub
breaks per 40mof axonwere considered damaged and calculated as the
percentage total of all TH-positive axons.
Autophagy. Cells were transfectedwith aGFP-tagged LC3 expression vec-
tor (kindly provided byDr. ChrisWeihl,WashingtonUniversity) atDIV5-6
aspreviously reported (Kumaet al., 2007).Aday later, cellswere treatedwith
2MMPP for the indicated time, fixed, and immunostainedwith a rabbit
anti-TH antibody (Pel-Freez Biologicals). Cy3-conjugated secondary anti-
bodies (Jackson ImmunoResearchLaboratories)wereused for visualization.
TH-positive neurons with LC3-GFP granules were counted using Stereo
Investigator (MBF Bioscience).
Optical imaging. At DIV12–14, mitochondria on the axonal chamber
side were labeled with 25 nM MitoTracker Red (MTR; Invitrogen). Plas-
mids containing mitochondrially targeted Dendra2 and synaptophysin
fused in frame with cerulean (Syn-Cer) were provided by Evrogen and
Dr. Rachel Wong (University of Washington, Seattle, WA), respectively.
Subsequently, mitochondrially targeted Dendra2 and Syn-Cer were in-
serted into the FUGW lentiviral expression vector provided byDr. Jeffrey
Milbrandt (WashingtonUniversity). Lentiviral preparations were gener-
ated using HEK 293T cells as described previously (Araki et al., 2004).
DA/GFP cultures were inoculated with virus at DIV2 for 4–6 h and
imaged at DIV12–13. Images were taken using a Zeiss LSM510 Meta
NLO Multiphoton System (Carl Zeiss) on Axiovert 200M inverted mi-
croscope with 40 water objective [C-Apochromat 40/1.2W Corr.1.2
numerical aperture, collar correction (0.14–0.18)] equipped with a 5%
CO2/37°C controlled chamber. Filter sets used for visualizing a given
fluorescent marker included 488 nm argon laser and 505 long pass emis-
sion filter (GFP and Dendra2), 543 nm HeNe laser and 560 long pass
emission filter [MTR, tetramethylrhodamine ethyl ester (TMRE), or
tubulin-mCherry), and 458 nm argon laser and 466–514 meta emission
filter (Syn-Cer). Sixty images at 5 s intervals were acquired before addi-
tion of toxin and then again 30 min after 2 M MPP treatment.
Image analysis. Kymographs were created using ImageJ/Multiple Ky-
mograph (NIH, Bethesda,MD). In all cases, directionwas determined by
identifying the axonal terminal from tile scanned images. To calculate
particle speed in each direction, the following approach was adopted.
Diagonal lines were drawn for each moving particle on a kymograph.
Angle and length information were collected for each particle’s diagonal
line. Distance and time were calculated using the following equations in
which 112.5 m was the frame length, 512 the pixel size, and 5 s the
interval of time-lapse images:
Distance (m) 112.5 * Length * COSRADIANS(Angle)/512,
(1)
Time (s) 5 *  Length * SINRADIANS(Angle)}. (2)
Total numbers of particles were obtained using particle analysis with a
threshold image.Only particlesmoving aminimumof 5min length for
at least 15 s within the imaging time were counted. Particle size was
assessed using ImageJ/Particle analysis. Anterograde movements are ex-
pressed as positive integerswhereas retrogrademovement is expressed by
negative integers.
[3H]Dopamine release. DA release on the microchamber devices was
measured as described previously (Lotharius and O’Malley, 2000).
Briefly, cells were loaded in both somal and axonal sides with 2.4Ci/ml
[ 3H]DA/Krebs–Ringer solution for 20 min at 37°C and washed 3 times
for 3 min. Radioactive counts from a wash sample were measured using
a Beckman scintillation counter and used as a control for basal levels of
[ 3H]DA release. Cells were then treated with MPP for 10 min, and the
amount of [ 3H]DA released during this time period was counted. Cul-
tures were then washed extensively and maintained in [3H]DA-free
Krebs–Ringer solution. Following medium collection, cells were lysed in
0.1 N perchloric acid by freeze thawing, and residual, intracellular
[ 3H]DA was measured. Total counts and percentages were calculated.
Mitochondrial membrane potential and size. Cells were loaded with
either 50 nM TMRE (Invitrogen) or MTR for 15 min and medium was
subsequently added for a final concentration of 25 nM. Mitochondrial
potential was assessed based on changes in TMRE fluorescence before
and after toxin treatment as described byWard (2010). The cross area of
axonal mitochondria was estimated by MTR fluorescence using ImageJ/
particle analysis.
Statistical analysis. One-way ANOVA and unpaired two-tailed Stu-
dent’s t test were used for statistical analysis (SAS, GraphPad Software).
Results
MPP causes neuritic degeneration and autophagy before cell
body loss
Because MPP serves as a substrate for the plasma membrane
DA transporter (Storch et al., 2004), its toxic effects are highly
selective for DA neurons versus the non-DA interneurons that
predominate dissociated mesencephalic cultures. Consistent
with in vivo results showing that loss of DA terminal fields occurs
earlier and is more pronounced than cell body loss (Serra et al.,
2002; Meissner et al., 2003), MPP leads to a significant loss of
neurites in dissociatedDA cultures before cell bodies are affected.
As early as 12 h post-MPP treatment, neurite loss was apparent
(Fig. 1A). It should be noted that most of the “neurites” mea-
sured here have morphological features of proximal dendrites in
that they exhibit a wide diameter that tapers away from the cell
body. When compartmentalized axons (Fig. 2A,B) were assessed
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for fragmentationat 12h, significantlymore
fragmentation was observed (70.3 	 8.9%
nontreatedaxoncontrol versus50.4	8.4%
nontreated dendritic control, p 
 0.05).
These data suggest that axons aremore vul-
nerable than dendrites in the presence of
MPP. In contrast, TH-positive cell bodies
were not significantly reduced until 24 h
later and then by only40% (Fig. 1B). Be-
cause DA uptake sites vary among DA neu-
rons from the substantia nigra pars
compacta (SNpc) and ventral tegmental
area (VTA) (Storch et al., 2004) and that the
described dissociated DA cultures would
contain neurons from both populations,
some variability among MPP effects is to
be expected. Thus, a 40% death level might
represent all of the DA SNpc neurons, yet
only a small fraction of DA neurons arising
from the VTA.
SinceMPP is thought to depolymerize
microtubules (Cappelletti et al., 2005), we
stained DA/GFP cultures with antibodies
directed against acetylated -tubulin, a
marker of stable microtubules, and exam-
ined DA axons for the presence of beading
and/or fragmentation. “Beading” was first
observed by 6 h (Fig. 1C, arrowheads), al-
though no significant fragmentation was
observed at this time point (Fig. 1D). To
confirm and extend this result, the integrity
of tubulinwas also assessedby introducinga
tubulin-mCherry construct into dissociated
DA cultures. The mCherry-positive axons
were examined for breaks in DA (GFP)
and non-DA (GFP) processes at various
time points following MPP treatment.
ConsistentwithMPP effects on acetylated
-tubulin, significant axonal disintegration
in DA neurons was not seen until 6 h post-
treatment, which exceeded 80% by 24 h
(Fig. 1E,F). Together, these data indicate
that MPP affects one important compo-
nent of axonal structure, namely themicro-
tubule tracks, 12–18 h before significant cell
body loss is observed.
MPP has been shown to induce au-
tophagy, a catabolic system to degrade
and recycle damaged proteins and/or or-
ganelles (Yang andKlionsky, 2010)within
24 h in DA neurons (Zhu et al., 2007). To
determine whether the disruption of
microtubule tracks preceded the induc-
tion of autophagic markers such as LC3
(microtubule-associated protein 1, light
chain 3; also known as ATG8) (Kadowaki
and Karim, 2009), we transfected an LC3-
GFP clone intoDA cultures andmeasured
the appearance of autophagic granules.
Under normal conditions, LC3-GFP fluo-
rescence exhibits a diffuse cytoplasmic
distribution (Fig. 1G). As early as 3 h after
toxin treatment, LC3 takes on a punctated
Figure 1. Neurite degeneration,microtubule disruption, and autophagy precedeDA cell death followingMPP treatment.A, Disso-
ciated DA neuronswere treatedwith 1MMPP for indicated times and then fixed and immunostainedwith rabbit polyclonal anti-TH
antibody.B, QuantificationofTH-positive cell bodiesandneurites remainingafter toxin treatment.Numbersof TH-positive cell bodiesand
neuriteswere counted using Stereo Investigator. Neuriteswere significantly reduced after 12 h of treatment, whereas the number of cell
bodiesdidnot significantly changeuntil 24h.Datadenote themean	SEMof representativedeterminationsmade in three independent
experiments. C, Integrity of microtubule tracks was assessed by measuring tubulin fragmentation before and after MPP treatment.
Compartmentedaxons (describedbelow)were fixedafter 3, 6, and24hofMPP treatmentand stainedwithantibodiesdirectedagainst
AcTubandTH.Beadingisseenasearlyas6h(insert,arrowheads)andfragmentationat24h(arrow).D,TH-positiveaxonswithfragmented
acetylatedtubulinwerequantified.OnehundredtothreehundredTH-positiveaxonswerecountedperdishandthreedisheswerecounted
pergroup.E, Integrityofmicrotubule trackswasalsoassessedbytransfecting tubulin-mCherry intoDA/GFPculturesatDIV6.Followingthe
addition of 2M MPP, live images were acquired at the indicated times. F, Tubulin intensity was expressed as percentage control.
Mean	SEMmade in three independentexperiments, *p0.05,**p0.001, compared to0h; #p0.05, compared toDAat24h.G,
AutophagywasassessedbyintroducingaGFP-taggedLC3expressioncloneatDIV6andtreatingDAneurons1dlaterwith2MMPP.The
formationofLC3-positivegranuleswasmeasuredasindicatedbyimmunostaining.LowerpanelsshowLC3fluorescencewithinTH-positive
axons before (top) and after (bottom) toxin treatment. For clarity, only LC3 fluorescence in axons is shown.H, The number of TH-positive
neurons with at least three LC3-GFP granules was counted and expressed as percentage of all neurons that were both TH positive and
LC3-GFPpositive, regardlessofwhether theLC3-GFPsignal in theseneuronswasdiffuseorpunctuate. Scalebars:A,C,E, 10m,G, 1m.
H,Mean	 SEM in three independent experiments, *p 0.05. In all bar graphs, hatching indicates toxin treatment.
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appearance as it localizes to the inner membrane of forming au-
tophagosomes (Fig. 1G,H). This observation confirms and accel-
erates the timeframe reported by Zhu et al. (2007). Moreover,
these results suggest that even before damaged microtubules are
apparent, other toxin-induced molecular events induce hall-
marks of autophagy.
MPP disrupts mitochondrial axonal transport
MPP also inhibits complex I, leading to mitochondrial dysfunc-
tion (Murphy et al., 1995). To analyze mitochondrial movement,
size, andmembranepotential (m) inDA
processes, we initially used a microfluidic
strategy (Taylor et al., 2005). However, DA
neurons attached poorly and were highly
susceptible to shear stress resulting from
plating, media changes, and/or toxin addi-
tion. Using a simplified chamber design
(Ivins et al., 1998), we established compart-
mented cultures such that: (1) axons were
segregated from cell bodies and dendrites;
(2) transport direction was easily discerned,
imaged, and quantified; and (3) cell bodies
or axons could be independently exposed to
drugs, toxins,DNA, etc. (Fig. 2A).Whenwe
used dissociated cultures from DA/GFP
mice,DAaxon terminals couldbe identified
via GFP fluorescence (Fig. 2B). Immuno-
staining with the dendritic marker MAP2
(microtubule-associated protein 2) or ax-
on-preferring tau verified that processes
that grew under the glass coverslip were ax-
ons, not dendrites (Fig. 2C). To avoid over-
lapping fluorescent emissions in analyzing
mitochondrial movement, we considered
several approaches. These included: (1) lip-
id-based transfectionswithmitochondrially
targeted DsRed2 (mtDsRed2) and/or the
photoactivatable fluorescent protein Den-
dra2 (mtDendra2); (2) transductions with
the same constructs packaged as lentiviral
particles; and (3) mitochondrial dyes such
as MTR and TMRE. In the first scenario,
finding fluorescently labeled mitochondria
in DA/GFP axons for live imaging is ham-
pered by the low numbers of DA neurons
typically isolated (2–5% of the total) and
low transfection efficiencies in these cul-
tures (5%). The second scenario, lenti-
viral transduction of fluorescent proteins
targeted to the mitochondria (mtDsRed2;
mtDendra2), was more efficient and, at
least with mtDendra2, provided the op-
tion of following particles after photocon-
version. Caveats associated with the third
scenario include the notion that mito-
chondrial dyes might interfere with mo-
bility (Buckman et al., 2001; Wang and
Schwarz, 2009). Thus we started these
studies using a targeted mtDendra2 lenti-
virus. Although Dendra normally emits at
the same wavelength as GFP before exci-
tation, it is easy to discern mitochondri-
ally targeted Dendra in DA axons because
the latter typically exhibit a smooth, ho-
mogenous pattern of GFP expression distinct from the tubulove-
sicular appearance ofmtDendra2 (Fig. 2D). That these structures
represent mitochondria can be shown by colocalization with the
fluorescent lipophilic cation TMRE, which rapidly accumulates
inmitochondria (Fig. 2D). Unfortunately, in our systemmtDen-
dra2 did not photoconvert with the efficiency or at the wave-
length originally claimed (Gurskaya et al., 2006); nonetheless,
analysis of nonconverted mtDendra2 particles showed that
MPP decreased total numbers of moving mitochondria (Fig.
Figure2. MPP rapidlydecreasesmitochondrialmovement inDAaxonsas shownbymtDendra2.A, Diagramofmicrochamber
device. B, Transmitted light image of segregated axons derived from DIV12 DA/GFP cultures in the top panel, GFP fluorescence in
the middle panel, and the merged image in the bottom panel showing TH-positive and TH-negative axons in same field. C,
Immunostaining of the axonal side with TH, the axonal marker Tau, and the dendritic marker MAP2. Tau but not MAP2-positive
processes is present on axonal side. Scale bar, 10m. D, mtDendra2 colocalizes with TMRE. Despite presence of nonconverted
mtDendra2, DA axon is easily identified. E, Axonal movement of mitochondria. Mitochondria labeled with mtDendra2 were
imaged for 5min at 5 s intervals after 30min incubation with andwithout 2MMPP. For consistency, mitochondrial measure-
ments were assessed near the axon terminal at least 2 mm away from the cell bodies. Resulting kymographs are shown below. F,
Number ofmovingmitochondria per 100mlength of axonwas calculated.G, Speedwas calculated as described inMaterials and
Methods. F, G, Mean	 SEM, *p 0.05, total of 17 (control) and 14 (MPP-treated) axons derived from at least 7 dishes in 3
independent experiments. The anterograde speed (Antero) was decreased and the retrograde speed (Retro) increased as early as
30 min after MPP treatment. Scale bars: B–D, 10m. Hatching indicates toxin treatment.
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2E,F ). Moreover, MPP treatment decreased mitochondrial
speeds in the anterograde direction but increased them in the
retrograde direction (Fig. 2G).
Despite the usefulness ofmtDendra2, the small number ofDA
neurons and variability associated with transduction still made
acquiring sufficient data in multiple experimental paradigms lo-
gistically challenging. In contrast, mitochondrial dyes have the
benefit of labeling all mitochondria within a chamber, ensuring
adequate numbers for analysis despite potential limitations such
as diffusion of fluorescence, quenching, and interference with
bioenergetic states (Buckman et al., 2001). At least some of these
limitations can be overcome when low concentrations (50 nM)
ofMitoTrackers such asMTR are used (Buckman et al., 2001; Rui
et al., 2006; Konzack et al., 2007; Trimmer et al., 2009). In our
studies, excellent loading and labeling of mitochondria was
achieved using even lower concentrations of MTR (25 nM). At
this concentration, MTR labeled exactly the same structures that
TMRE did (data not shown). More importantly, when an iden-
tical experimental protocol was used to measure MTR-labeled
mitochondria, essentially the same results as those for mtDen-
dra2 were produced (Fig. 3). In either case, we observed that like
other neurons (Kang et al., 2008),70% of all axonal mitochon-
dria were stationary (Kang et al., 2008). Of those mitochondria
that were moving, over 50% had stopped after only 30 min of
MPP treatment (Figs. 2F, 3B). Moreover, the number of mov-
ingmitochondria was reduced in either the anterograde or retro-
grade direction (Figs. 2G, 3C). In agreement with previously
published values (Brown, 2003),motileDAmitochondriamoved
with an average speed of 0.32 m/s in the anterograde direction,
whereas a slower rate was observed in the retrograde direction
(0.26 m/s) (Figs. 2G; 3C). Following MPP treatment these
rates were reversed: anterograde velocity was reduced whereas
retrograde speed was accelerated (Figs. 2G, 3C). Thus, MPP
rapidly affects both the fraction of motile DA mitochondria and
the speed at which they travel. These data suggest that in this cell
system and at this concentration MTR is a reliable measure of
mitochondrial mobility. Importantly, using two different ap-
proaches essentially the same results were observed: MPP rap-
idly reduced overall mitochondrial motility in DA axons; among
motile mitochondria, anterograde transport was slower yet ret-
rograde transport was increased.
MPP does not affect vesicular transport
To determine whether MPP affects all cargo movement or just
that ofmitochondria, DA/GFP cultures inmicrochamber devices
were transducedwitha lentivirus expressingSyn-Cer (Fig. 4A,B).As
shown by others (Nakata et al., 1998), the synaptophysin se-
quence targets small, rapidly moving particles that do not colo-
calize with MTR (Fig. 4A). Despite inhibiting mitochondrial
movement within 30 min, MPP did not affect the number or
speed of synaptophysin-tagged particles moving in either direc-
tion (Fig. 3B–D). Since numerous studies have also shown that
MPP is taken up into vesicular compartments where it rapidly
(10 min) leads to the displacement of DA (Lotharius and
O’Malley, 2000), which was reproduced in our microchamber
devices (Fig. 5), these results emphasize that the presence of a
neurotransmitter is not a requirement for transport. As synapto-
physin labels only synaptic vesicles, we also examined all moving
particles using transmitted light images. After subtracting out
mitochondria from MTR-colabeled axons, the remaining parti-
cles showed no significant difference in movement following
toxin treatment (data not shown). These data underscore the
specificity of the MPP effect on mitochondria versus general
axonal cargos and also rule out damaged microtubules as a con-
tributing factor in decreased mitochondrial motility.
MPP rapidly depolarizes axonal mitochondria
MPP inhibition of complex I leads to ROS, loss of m, and
eventually loss of ATP (Ali et al., 1994). Previously we showed
thatMPP-induced ROS changes occurred within 15min in DA
cell bodies using dihydrorhodamine and dihydroethidium (Lo-
tharius et al., 1999; Lotharius and O’Malley, 2001). Although we
could confirm our cell body results, we could not quantitate ROS
changes in DA axons with these reagents (data not shown). To
determine whether m was altered over the same time period
that movement was reduced, segregated DA/GFP axons were la-
beled with the sensitive m indicator TMRE before acquiring
baseline images. After 30 min of toxin treatment, m was sig-
nificantly reduced in DA (79.8 	 7.23% decrease in TMRE
fluorescence) (Fig. 6B) but not non-DA axonal mitochondria
( 12.9 	 7.34% TMRE fluorescent decrease) (Fig. 6B), high-
lighting the DA-specific nature of the MPP effects. Because
bioenergetic declines are thought to shift fusion/fission dynamics
toward fission, resulting in smaller mitochondria (Benard et al.,
2007), wemeasuredmitochondrial size. AlthoughTMRE-labeled
mitochondria appeared to undergo a decrease in size (Fig. 6A),
this was due to the loss of TMRE fluorescence since MPP treat-
ment didnotdecrease the size ofMTR-labeled axonalmitochondria
(Fig. 6C). Thus, MPP rapidly depolarized DA mitochondria but
did not reduce their size, at least in the time frame tested. Collec-
tively, these results are consistent with recent work in hippocampal
Figure 3. MPP rapidly decreases mitochondrial movement in DA axons as shown by Mi-
toTracker Red. A, Axonal movement of mitochondria. Mitochondria were labeled with 25 nM
MTR and imaged for 5 min at 5 s intervals after 30 min of incubation with and without 2M
MPP. Mitochondrial measurements were assessed as described in Figure 2. Resulting kymo-
graphs are shown below. B, Total and moving mitochondria were counted and the rate of
motile mitochondria was calculated. C, Speed was calculated as described in Materials and
Methods.B, C, Mean	 SEM, *p 0.05, total of 114 (control) and 175 (MPP-treated) axons
from 15 and 28 dishes in 13 independent experiments. Total length of control and MPP-
treated axons sampled were 10,716 and 16,732 m, respectively, and the total numbers of
mitochondria examined were 1762 and 2632, respectively. The anterograde speed (Antero)
was decreased and the retrograde speed (Retro) increased as early as 30 min after MPP
treatment. Hatching indicates toxin treatment.
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neurons showing thatdepolarizedmitochondria travelmore rapidly
in a retrograde direction (Gerencser and Nicholls, 2008).
Thiol-based reagents rescue disrupted transport, neurites,
and cells
What are the underlying mechanisms associated with MPP-
mediated alterations in transport? Conceivably, MPP-compro-
misedmitochondria block transport due to the ATP dependency of
themolecularmotors. In the squid axoplasm preparation, however,
MPP effects on fast axonal transport were independent of ATP
production. Rather, MPP treatment led to axonal activation of
caspase-3, which in turn cleaved PKC into its catalytically active
fragment (Morfini et al., 2007). Like the squid preparation, increas-
ing ATP levels in bona fide DA axons via glucose preincubation
(ATP levels increased from 3.93	 0.20 1012 to 4.88	 0.11
1012 mole/g of protein, p-value
 0.002) did not rescue MPP
effects onmitochondrial motility (Table 1). One caveat to this find-
ing is that there are nomethodologies tomeasure ATP levels in situ.
Thus, we cannot rule out the possibility that regional variations in
ATP levels might underlie the loss of mitochondrial movement.
Unlike the invertebrate preparation, neither the PKC (Go¨6976)
nor the caspase inhibitor, Csp3I-II, blocked MPP effects in DA
axons (Table 1) although both inhibitors significantly blocked
6-OHDA-induced DA cell death (Go¨6976: 45.94 	 11.48% and
Csp3I-II: 50.70 	 11.58% protection). We also tested whether
Ca2 chelators would affect mitochondrial transport since Ca2
plays a role in axonal loss (Stirling and Stys, 2010) and is also
implicated in DA neurodegeneration
(Surmeier, 2007). Neither EGTA nor
BAPTA-AM prevented MPP-disrupted
mitochondrial transport at concentra-
tions showing intracellular Ca2 changes
in axons using Oregon Green (data not
shown). Because axonal injury induces
activation of the c-Jun N-terminal kinase
(JNK) family in the peripheral nervous
system (Abe and Cavalli, 2008), we exam-
ined whether the general JNK inhibitor
SP600125 could rescue toxin-blockedmi-
tochondrial motility in segregated DA
axons. SP600125 did not affect mitochon-
drial trafficking (Table 1) nor did it pre-
vent MPP-mediated DA cell death at a
concentration that was effective for block-
ing t-butylhydroperoxide-induced DA
cell death (64.08	 2.18% protection).
Given that MPP generates ROS via
inhibition of complex I or via release of
vesicular DA followed by its cytoplasmic
oxidation (Lotharius et al., 1999; Lo-
tharius and Brundin, 2002), we tested
N-acetylcysteine (NAC; precursor of gluta-
thione), Mn(III)tetrakis(4-benzoic acid)
porphyrin (MnTBAP, a superoxide dismu-
tase mimetic), and glutathione monoethyl
ester (GSHEE; membrane-permeable
GSH) as axonal protectants. Remarkably,
pretreatment with the redox-sensitive
neuroprotectants NAC and GSHEE com-
pletely rescued MPP-induced changes
in numbers of motile mitochondria,
whereas the anti-oxidant, MnTBAP was
ineffective at a concentration of 100 M
(Table 1). Moreover, NAC pretreatment not only rescued mi-
tochondrial motility but also MPP-induced neurite and cell
body loss (Fig. 7). Thus, NAC or similar drugs can potentially
be useful therapeutic tools. Although these differences may
simply reflect extruded axoplasm responses versus an intact
axon, they may also reflect clear differences between verte-
brate and invertebrate mitochondrial trafficking systems and
indicate that redox equilibria may play a critical role in at least
the mammalian processes.
DAmitochondria are smaller and slower than
non-DA mitochondria
Recent studies show that nigral DA neurons have lower numbers
of mitochondria in their cell bodies and dendrites than non-DA
neurons (Liang et al., 2007). To determine whether differences
exist in organelle size or movement between DA and non-DA
axons, we measured various critical attributes of axonal mito-
chondria and synaptophysin-tagged vesicles (Table 2). Consis-
tent with the in vivo study (Liang et al., 2007), DA mitochondria
are about half the size of non-DA mitochondria and are trans-
ported almost three times slower. Although the density of mito-
chondria along the axon is the same, there are fewer moving
mitochondria inDA versus non-DA axons.Mitochondrialmem-
brane potential is the same. Similarly, the number of moving
vesicles per unit length axon is reduced in DA versus non-DA
axons, but their speed is not (Table 2).Nodifferencewas found in
other general moving particles. Importantly, non-DAmitochon-
Figure 4. MPP does not affect axonal movement of synaptic vesicles. Dissociated DA/GFP cultures were transduced with
Syn-Cer lentivirus at DIV2. Vesicular movement was assessed on DIV12–13 before and after toxin treatment. A, Although some
vesicles were clumped and appeared to overlap mitochondria, individual vesicles labeled with Syn-Cer (arrows) were also visual-
ized adjacent tomitochondria labeledwithMTR (arrowheads).B, Vesicularmovementwas observed for 5min before and after 30
min of incubationwith andwithout 2MMPP. Because of the smaller size of vesicular particles and the relative “dimness” of the
cerulean emission, tracks ofmoving particles are shownbelow for clarity. C,D, Quantification ofmoving particles (C) and speed (D)
were determined as described in Materials andMethods. Scale bar: 10m.Mean	 SEM, ns, nonsignificant, total of 25 (control)
and 38 (MPP-treated) axons from 4 and 5 dishes in 4 independent experiments. Total lengths of control and MPP-treated
axons sampled were 2247 and 3497m, respectively. Hatching indicates toxin treatment.
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dria were not affected by MPP in terms of size, mobility, or
speed (Table 3). Given that these data were acquired from the
same experiments inwhichDAaxonswere analyzed, they serve as
useful internal controls showing that the loss of signal or change
in parameter is not due to bleaching caused by imaging or other
non-specific effects. Together, these data suggest that DA axons
may be more susceptible to dysfunction than non-DA axons due
to innate differences in axonal mitochondrial characteristics.
Discussion
Mounting evidence suggests that axonal dysfunction precedes the
death of cell bodies in many neurodegenerative disorders, espe-
cially PD. The present study uses cellular, optical, and pharma-
cological techniques to provide new insights into the biological
changes underlying toxin-mediated DA axonal impairment. Re-
sults demonstrate: (1) that the PD-mimetic MPP affects DA
neuritic processes and microtubule tracks 12–18 h before cell
bodies appear altered, and neuritic autophagic puncta are vis-
ible by 3 h; (2) MPP halts mitochondrial trafficking in DA
but not non-DA axons within 30 min, an event which precedes
autophagy and loss of microtubules; (3) remaining motile mi-
tochondria exhibit decreased anterograde movement but in-
creased retrograde trafficking; (4) MPP effects are specific
for mitochondria, as synaptophysin-tagged vesicles and other
detectable moving particles continue normal movements in
either direction; (5) decreased mitochondrial trafficking is ac-
companied by a loss of m; (6) loss of mitochondrial move-
ment is not associated with ATP loss but rather redox changes;
(7) DA mitochondria are smaller and slower than non-DA
organelles, suggesting cell type-specific differences exist for
axonal mitochondria.
Althoughwidely used as an animalmodel of PD, themechanism
bywhichMPP kills DAneurons remains equivocal. Previously we
have shown that MPP induces a protein synthesis-dependent yet
caspase-independent cell death in DA neurons that is partially me-
diated by ROS (Lotharius et al., 1999). In those studies and this one,
DA cell bodies die over a period of 48 h following toxin treatment,
although early loss of neurites is consistently observed (Lotharius et
al., 1999) (Fig. 1). Increased free radical spe-
cies such as mitochondrial superoxide have
been proposed as an important mechanism
underlying the neurotoxicity of MPP
(Jackson-Lewis and Smeyne, 2005). Previ-
ously, however,wehave shown thatMPP-
induced ROS are primarily derived from
toxin-released vesicular DA (Lotharius and
O’Malley, 2000) (Fig. 5). Since redistrib-
uted, cytoplasmic DA is thought to form a
number of oxidized toxic metabolites, in-
cluding DA quinones (Hastings, 2009), it is
perhapsnot surprising thatMnTBAP,acell-
permeable SOD mimetic, did not show a
protective effect.Conceivably,other typesof
ROS, including hydroxyl radicals and/or ni-
tric oxide (Jackson-Lewis and Smeyne,
2005; Obata, 2006; Yokoyama et al., 2008),
might also play a role in MPP-mediated
neurotoxicity. What role, if any, these fac-
tors play in axonal transport awaits future
study.
Recently, Cartelli et al. (2010) also re-
ported that MPP affects mitochondrial
trafficking in the pheochromocytoma cell
Figure 5. MPP rapidly leads toDAefflux. [ 3H]DA release assayswere performedexactly aswe
have described previously except that 10 min treatment windows were used instead of 6 min (Lo-
tharius and O’Malley, 2000).A, MPP dose–response curve; EC50 for DA release is 0.42	 0.04M
(mean	 SEM). B, MPP-mediated DA release can also be assessed in segregated axons. Each
chamberwas briefly incubatedwith [ 3H]DA,washed extensivelywith PBS, and then treatedwith or
without1MMPP for10min.Chamberswerewashedandthentreatedwith60mMK to release
vesicularcontentsandfinally lysedtoassessremainingDAlevels(LothariusandO’Malley,2000). Inthe
toppanels, highK releases50–60%of intracellularDA levels in control cell bodies (left) andaxons
(right) whereas, 1 M MPP releases95% (bottom panels). Axon-only chamber represented
about 25%of transmitter levels in cell body chamber.
Figure 6. MPP rapidly depolarizes DAmitochondria.A, Mitochondria in axons fromDA/GFP cultureswere labeledwith 25 nM
TMRE and then assessed before and 30 min after MPP treatment. Scale bar: 5m B, MPP led to significant differences in
masmeasured inarbitraryunits (AU; arrows).C, Cross sectional areasofmitochondria labeledwithMTRweremeasuredbefore
and after toxin treatment using ImageJ particle analysis. Hatching indicates toxin treatment.B, C, Mean	 SEM of representative
determinations from three independent experiments, **p 0.001.
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line PC12. In this study, however, MPP led to microtubule
impairment before transport dysfunction. In contrast, the pres-
ent findings show thatmitochondrial dysfunction (30min) (Figs.
2, 3, 6) precedesmicrotubule fragmentation inDA axons (Fig. 1).
Although microtubule polymerization is a GTP-dependent pro-
cess (Carlier and Pantaloni, 1981), it is also controlled by ATP-
dependent pathways. For example, the energy-sensing AMP-
activated protein kinase is required for microtubule stabilization
(Nakano et al., 2010). Conceivably, MPP-mediated energy depri-
vation over the course of 6 h may underlie microtubule fragmenta-
tion (Fig. 1).
A direct effect of MPP on axonal transport was first seen in
the isolated squid axoplasm (Morfini et al., 2007). Despite the
evolutionary distance between the squid andmouse, in both cases
MPP decreased anterograde trafficking while increasing retro-
grade movement. However, in the squid axoplasm, MPP af-
fected all organelles and vesiclesmoving via fast axonal transport,
whereas in bona fide DA neurons, toxin-mediated effects were
specific for mitochondria. Although model preparations such as
the squid axoplasm and/or the noradrenergic peripheral tumor
cell line can yield valuable insights, our results underscore the
uniqueness of a midbrain DA neuron. Indeed, the rapidity and
specificity of MPP actions on DA axons are striking: toxin ef-
fects onmitochondria occur hours before microtubule tracks fall
apart and before cell bodies are lost (Fig. 1). Moreover, neither
non-DA mitochondria nor any other detectable type of moving
particle is affected by toxin treatment, confirming the integrity of
the microtubule tracks (Table 2).Together, these data point to an
Figure 7. NAC protects DA cell bodies and neurites from MPP-induced degeneration. A,
DissociatedDAneuronswere pretreatedwith 2.5mMNAC for 18 h, treatedwith 2MMPP for
24 h, and then fixed and immunostainedwith rabbit polyclonal anti-TH antibody. Scale bar: 10
m B, Quantification of TH-positive cell bodies and neurites. Cell bodies and neurites were
significantly protected by NAC.Mean	 SEM from three independent experiments, *p 0.05,
compared to control, #p 0.05, ##p 0.001, compared to MPP.





 Glucose 6.19	 1.26
 Csp3I- II 10.96	 2.58
 Gö6976 6.16	 3.42
 EGTA 4.80	 2.70
 SP600125 4.63	 0.63
MnTBAP 9.49	 1.51
 NAC 18.62	 3.53b
 GSHEE 15.49	 3.10b
Numbers are mean	 SEM.
ap 0.05 compared to control.
bp 0.05 compared to MPP. Concentrations: MPP, 2M; glucose, 20 mM; Csp3I-II (caspase-3 inhibitor
II), 5M; Gö6976, 500 nM; EGTA, 2.5mM; SP600125, 10M; MnTBAP, 100M; NAC (N-acetylcysteine),2.5mM;
GSHEE, 5 mM.
Table 2. DA axons exhibit uniquemitochondrial and vesicular characteristics
DA Non-DA
Density ‡ 8.89	 0.86 9.50	 0.82
Moving particles ‡ 1.93	 0.22 2.49	 0.24*
Speed (m/s)
MTR 0.28	 0.05 0.79	 0.07**
mtDendra2 0.30	 0.02 0.61	 0.11**
Cross area (m2)
MTR 1.07	 0.12 2.52	 0.11**
mtDendra2 0.94	 0.06 2.17	 0.47*
m (AU) 58.5	 3.22 65.2	 4.08
Synaptic vesicles
Moving particles ‡ 3.93	 0.30 5.71	 0.63*
Speed (m/s) 0.56	 0.05 0.52	 0.03
All particles
Moving particles ‡ 6.35	 1.22 6.79	 0.48
Speed (m/s) 0.12	 0.01 0.14	 0.01
‡Number/100m.Numbers aremean	 SEM, *p 0.05, **p 0.001, compared toDAneurons. ForMTR studies,
33 dishes from 11 independent experiments were evaluated; for mtDendra2 studies, eight dishes from four inde-
pendent experiments were assessed. For synaptic vesicles, three dishes from three independent experiments were
assessed. When measuring all particles, seven dishes from seven independent experiments were measured. In all
cases 3–5 axons per dish were analyzed.




MTR 2.49	 0.24 2.01	 0.23
mtDendra2 1.92	 0.61 2.48	 0.14
Speed (m/s)
MTR 0.79	 0.07 0.71	 0.09
mtDendra2 0.61	 0.11 0.65	 0.19
Cross area (m2)
MTR 2.52	 0.11 2.36	 0.19
mtDendra2 2.17	 0.47 2.57	 0.46
Numbers are mean 	 SEM. For MTR studies, 33 dishes from 11 independent experiments were evaluated; for
mtDendra2 studies, eight dishes from four independent experiments were assessed. In all cases 3–5 axons per dish
were analyzed.
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early and profound toxin-mediated block of mitochondrial traf-
ficking that results inmitochondrial redistribution away from the
synapse back to the soma. Conceivably, damaged mitochondria
moving toward the soma could deliver signals from the axon to
the cell body, leading to the initiation of cell death.
Mitochondria undergo complex yet continual processes of
fusion and fission that are critical for the exchange of organelle
contents, repolarization, or degradation by autophagy (Chen and
Chan, 2009). Two PD-linked genes that are ubiquitously ex-
pressed have also been implicated in this process. Current data
indicate that PINK1 is selectively stabilized on depolarized mito-
chondrial membranes (Matsuda et al., 2010). This in turn acts as
a signal for Parkin recruitment, which tags Pink-positive depo-
larizedmitochondria for destruction via autophagy (Narendra et
al., 2008, 2010; Matsuda et al., 2010). The latter studies would
predict that following MPP treatment and bioenergetic de-
clines, PINK1 will be stabilized and Parkin will then be recruited
to the PINK-tagged organelles before the appearance of au-
tophagic puncta inDA axons. One caveat to thismodel, however,
is that the previous studies were conducted in cell lines. A recent
report examining PINK1 recruitment of Parkin in bona fide neu-
rons did not see depolarization-mediated Parkin recruitment or
autophagy (Van Laar et al., 2011). Thus, other mechanisms may
also contribute to the induction of these processes in neurons.
In addition to its role in monitoring mitochondrial dynamics
(Bueler, 2009), PINK1might directly affectmitochondrial motil-
ity since it also forms a complexwithMiro andMilton (Weihofen
et al., 2009). The latter proteins are known to recruit kinesin to
the mitochondria and promote motility along microtubule
tracks (Reis et al., 2009). Recently, an ROS-independent, redox-
dependent protein termed HUMMR (hypoxia-upregulated
mitochondrial movement regulator) was discovered that also inter-
acts with Milton and Miro to influence mitochondrial movement
and direction (Li et al., 2009). Knockdown of HUMMR decreased
anterograde movement of mitochondria and increased retrograde
movement (Li et al., 2009). Given thatMPP-disruptedmitochon-
dria exhibited decreased anterograde and increased retrograde
movement and that only the redox protectants NAC and GSHEE
prevented these axonal effects, it may be possible that HUMMR, in
conjunction with PINK1/Milton and Miro, plays a role in this
process. Although MPP-decreased mmay be sufficient to
reduce and alter mitochondrial movement, whether these or
other transport-associated proteins play ancillary roles awaits
future studies.
A recent study suggests that somal and dendritic DA mito-
chondria occupy only 40% of the area of non-DAmitochondria.
(Liang et al., 2007). Our cross-sectional measurements of mito-
chondria in DA axons versus non-DA axons mirror these results,
with DA mitochondria being only 40% of the size of their
non-DA counterparts (Table 2). Most importantly, axonal DA
mitochondria exhibit an instantaneous velocity that is almost
three times slower than non-DA mitochondria (Table 2). The
validity of these observations is underscored by the use of two
different mechanisms to measure mitochondrial properties
(MTR and mtDendra2) (Table 2) with essentially the same re-
sults. Moreover, since all measurements were taken from within
the same axonal fields, even if absolute numbers were affected by
experimental conditions, the actual results are relative to each
other. Presumably, this reflects inherent differences inDA axonal
mitochondria themselves; perhaps a unique outer membrane
protein interacts with a scaffolding protein that, in turn, binds to
a slower motor. Alternatively, DA axons might be slightly nar-
rower, slowing larger organelles and potentially contributing to
their smaller size. Thus, in addition to producing a transmitter
prone to oxidation (Hastings, 2009) and reliance upon L-type
Ca2 channels that appear to drain ATP resources (Chan et al.,
2010), DA neurons might also be less effective at delivering mi-
tochondria to sites of high energy usage such as synapses.
Redistribution of mitochondria away from sites of high ATP
usage would lead to axonal impairment, loss of synaptic connec-
tivity, and hence loss of function. Although mitochondrial redis-
tribution may not be the sole trigger of axonal dysfunction, it
occurs early and is consistent with increasedmitochondrial stain-
ing in the cell body (data not shown). This study, together with
the large amount of evidence suggesting that PD is associated
with axonal “dying-back,” underscores the necessity of develop-
ing therapeutics aimed at axons as well as cell bodies so as to
preserve circuitry and function. Because NAC pretreatment not
only prevented mitochondrial dysfunction but also preserved
neurites and cell bodies, NAC or drugs like it may serve a future
therapeutic role.
Notes
Supplemental material for this article (movies) is available at http://
thalamus.wustl.edu/faculty.php?id
4. This material has not been peer
reviewed.
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